Novo Nordisk Tailors Launch for COVID-era Customers
Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for. So, amid the pandemic, Novo Nordisk adjusted their launch to provide support customized for the time of COVID.